Nov 1 2019 - 12:00pm to 1:00pm
Location: Feil Family Research Building
"Molecular Neuroimaging as a Translational Tool for Traumatic Brain Injury (TBI) Drug Development" Esteban A. Fridman, M.D., Ph.D., Assistant Neuroscience Professor Weill Cornell Medicine (WCM) BMRI
Nov 1 2019 - 12:00pm
Speaker: Esteban A. Fridman, M.D., Ph.D., Assistant Professor of Neuroscience, BMRI, WCM
Oct 25 2019 - 12:00pm to 1:00pm
Location: Feil Family Research Building
"Stabilization of Munc18-1 function via target-specific pharmacological chaperones identified through an in silico screen" Debra Abramov, Tri-institutional MD-Ph.D. candidate, Burre Laboratory, BMRI, WCM
Oct 25 2019 - 12:00pm
Speaker: Debra Abramov, Tri-institutional MD-Ph.D. candidate, Burre Laboratory, BMRI, WCM
Location: Feil Family Research Building Conference Room 108
Oct 24 2019 - 4:00pm to 5:00pm
Location: Weill Auditorium
Marta Filizola, Ph.D. Graduate School of Biomedical Sciences Dean and Professor With an average of 130 Americans dying every day, and opioid drugs still representing the gold standard for pain management, there is an urgent need to identify innovative solutions to prevent life-threatening opioid overdoses and treat opioid use disorders. Clinical opioid drugs inhibit nociceptive signaling but also cause respiratory depression by targeting a G-protein coupled receptor, specifically the µ-opioid...
Oct 16 2019 - 12:00pm to 1:00pm
Location: Belfer Research Building
Routing Tau between and within Cells
Oct 11 2019 - 12:00pm to 1:00pm
Location: Feil Family Research Building
"The Role of CNS Endothelial Cell Derived Extracellular Vesicles as Biomarkers of Blood Brain Barrier Permeability in Multiple Sclerosis" Jennifer R. Linden, Ph.D. Instructor in Neuroscience, BMRI, WCM
Oct 11 2019 - 12:00pm
Speaker: Jennifer R. Linden, Ph.D., Instructor in Neuroscience, BMRI, WCM
Location: Feil Family Research Building Conference Room 108
Oct 10 2019 - 4:00pm to 5:00pm
Location: Weill Auditorium
Despite more than 50 years of clinical use as anxiolytics, anticonvulsants and sedative/hypnotic anti-A receptor optical reporters, the mechanisms underlying BenZoDiazepine (BZD) tolerance are poorly understood. BZDs potentiate the actions of Gamma-AminoButyric Acid (GABA), the primary inhibitory neurotransmitter in the adult brain, through positive allosteric modulation of 2 subunit-containing GABA type A receptors (GABAA receptors). Our current work focuses on defining key molecular events...